Newborn screening for pompe disease in Illinois: Experience with 684,290 infants

Barbara K. Burton*, Joel Charrow, George E. Hoganson, Julie Fleischer, Dorothy K. Grange, Stephen R. Braddock, Lauren Hitchins, Rachel Hickey, Katherine M. Christensen, Daniel Groepper, Heather Shryock, Pamela Smith, Rong Shao, Khaja Basheeruddin

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Statewide newborn screening for Pompe disease began in Illinois in 2015. As of 30 September 2019, a total of 684,290 infants had been screened and 395 infants (0.06%) were screen positive. A total of 29 cases of Pompe disease were identified (3 infantile, 26 late-onset). While many of the remainder were found to have normal alpha-glucosidase activity on the follow-up testing (234 of 395), other findings included 62 carriers, 39 infants with pseudodeficiency, and eight infants who could not be given a definitive diagnosis due to inconclusive follow-up testing.

Original languageEnglish (US)
Article numberijns6010004
JournalInternational Journal of Neonatal Screening
Volume6
Issue number1
DOIs
StatePublished - 2020

Keywords

  • Newborn screening
  • Pompe disease

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Immunology and Microbiology (miscellaneous)
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Newborn screening for pompe disease in Illinois: Experience with 684,290 infants'. Together they form a unique fingerprint.

  • Cite this

    Burton, B. K., Charrow, J., Hoganson, G. E., Fleischer, J., Grange, D. K., Braddock, S. R., Hitchins, L., Hickey, R., Christensen, K. M., Groepper, D., Shryock, H., Smith, P., Shao, R., & Basheeruddin, K. (2020). Newborn screening for pompe disease in Illinois: Experience with 684,290 infants. International Journal of Neonatal Screening, 6(1), [ijns6010004]. https://doi.org/10.3390/ijns6010004